Levi & Korsinsky notifies investors that it has commenced an investigation into Cryoport, Inc. (NASDAQ: CYRX) concerning potential violations of the federal securities laws.
On May 7, 2024, Cryoport announced “disappointing” first quarter earnings for fiscal 2024. Jerrell Shelton, CEO of Cryoport, attributed the weak earnings to a “difficult environment globally” and “softer than anticipated” revenue growth in the company’s Life Sciences Services segment. On this news, Cryoport’s stock price fell $3.20 per share or nearly 20% in the span of just a day.
If you suffered a loss on your Cryoport securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





